Welcome to the Technology Networks Research Store, leading strategic market analysis for the Biotech and Healthcare sector from the most trusted sources in the world. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (32)

5,000 - 9,999 (59)

10,000 - 49,999 (121)

50,000+ (45)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (21)

500 - 999 (13)

1,000 - 1,999 (48)

2,000+ (201)

Top stories

Veracyte appoints chief medical officer

Veracyte, Inc., a molecular diagnostics company, has appointed Neil Barth as the chief medical officer...more >>

Viracor-IBT partners with NKR for pre-transplant serology testing

Eurofins Scientific, a provider of bio-analytical testing services, has announced that its wholly-owned subsidiary, Viracor-IBT Laboratories, has partnered with The National Kidney Registry, or NKR, to streamline pre-transplant serology testing for kidney donors...more >>

Nichi-Iko Pharmaceutical reports higher Q1 net profit, provides annual outlook

Nichi-Iko Pharmaceutical Co., Ltd., a manufacturer of generic pharmaceutical products, has reported that net profit attributable to the parent company for the first quarter ended June 30, 2015 was JPY2.29 billion, compared to JPY1.91 billion for the same quarter ended June 30, 2014. For fiscal 2016, the company expects net profit attributable to the parent company to be JPY8 billion...more >>

Retractable Technologies reports earnings for Q2

Retractable Technologies Inc., a developer of safety syringes and other safety medical products, has reported that earnings applicable to common shareholders for the second quarter ended June 30, 2015 were $5.61 million, or $0.19 per diluted share, compared to a loss applicable to common shareholders of $1.62 million, or $0.06 loss per diluted share, for the same quarter ended June 30, 2014...more >>

More headlines

Sarepta appoints new members to strategic and scientific advisory board
Published 28 August 2015 - MarketLine

Vitrolife Q2 net income increases
Published 28 August 2015 - MarketLine

Zecotek signs agreements with ECM for 3D auto-stereoscopic display monitors
Published 28 August 2015 - MarketLine

Neurocrine completes subject enrollment in Phase III tardive dyskinesia trial
Published 28 August 2015 - MarketLine

BELLUS Health Q2 net loss decreases
Published 28 August 2015 - MarketLine

Emergent receives $44 million CDC contract for Vaccinia immune globulin
Published 28 August 2015 - MarketLine

Vasomedical reports net income for Q2
Published 28 August 2015 - MarketLine

Aeolus Pharmaceuticals reports net loss for Q3
Published 28 August 2015 - MarketLine

Chiome Bioscience reports higher H1 net loss, provides annual outlook
Published 28 August 2015 - MarketLine

Cipla Q1 net profit increases
Published 28 August 2015 - MarketLine

Spectral Medical Q2 loss decreases
Published 28 August 2015 - MarketLine

Browse all news >>